C3 glomerulonephritis is a clinicopathologic entity defined by the presence of isolated or
dominant deposits of C3 on immunofluorescence. To explore the effect of …

Results We identified 30 patients who met inclusion criteria. Median age was 25 years old
(interquartile range, 18–36), median creatinine was 1.07 mg/dl (interquartile range, 0.79 …

Results The study group comprised 97 patients (84% C3 glomerulopathy, 16% dense
deposit disease). Forty-two patients were treated with corticosteroids plus MMF, and this …

Abstract Background: C3 glomerulopathy (C3GP) is a recently identified and described
disease that has a high risk of progressing into end-stage renal disease. We aimed to …

We report the case of a 63-year-old man who presented with acute kidney injury, active
urine sediment, nephrotic syndrome, and hypocomplementemia after a recent report of a …

Objective To describe the clinicopathological features, complement abnormalities, triggers,
treatment, and outcomes of C3 glomerulopathy. Patients and Methods A total of 114 patients …

Whereas early classifications of membranoproliferative glomerulonephritis (MPGN) were
based on morphologic features, the modern approach is directed at immunofluorescence …

Results All patients presented with hematuria, associated with chronic renal failure and
proteinuria in five patients, three of whom had nephrotic syndrome. Five patients had …

C3 glomerulonephritis (C3GN) is a recently described disorder that typically results from
abnormalities in the alternative pathway (AP) of complement. Here, we describe the clinical …

Precise immunofluorescence criteria for C3 glomerulopathy remain to be defined. Here we
tested hierarchical immunofluorescence criteria with varying stringency for C3 …